약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
Download original image
Scheme 1. Synthesis of KEAP1 BRD4 PROTAC.
Reagent and conditions: (a) BnBr, K2CO3, EtOH, 70 oC, 81%; (b) Br2, AcONa, AcOH, r.t, 96%; (c) MeI, NaH, DMF, 0 oC to r.t, 79%; (d) Zn dust, AcOH, 0 oC to 45 oC, 59%; (e) NaNO2, 10% H2SO4 (aq.), 87%; (f) tert-Butyl acrylate, Pd(PPh3)4, P(O-Tol)3, DMF, 95 oC, 79%; (g) 13, [RhCl(Cod)]2, Et3N, Dioxane/H2O (2:1), 95 oC, 53%; (h) 16, DIAD, PPh3, anhydrous THF, r.t, 75%; (i) H2, Pd/C, MeOH, r.t, 98%; (j) NaH, Bromo acetic acid, THF, reflux, 95%; (k) (i) 19a-d, HATU, DIPEA, DMF, r.t, 45-60%; (ii) 4N HCl/Dioxane, r.t, 86-95%
Yakhak Hoeji 2024;68:276-86 https://doi.org/10.17480/psk.2024.68.4.276
© 2024 Yakhak Hoeji